Product: | Vitamin D3 | ||||
---|---|---|---|---|---|
Catalog Number: | 5335 | ||||
CAS Number: | 67-97-0 | ||||
Synonyms: | Cholecalciferol | ||||
Pricing: |
| ||||
Formula: | C27H44O | ||||
Chemical Purity: | >98% | ||||
Molecular Weight: | 384.64 | ||||
Structure: | |||||
Appearance: | White crystalline | ||||
Category: | Vitamin D3 | ||||
Stability: | Stable under recommended storage conditions. | ||||
Storage: | Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2-8°C | ||||
Transportation: | IATA: Hazard Class: 6.1; UN Number: UN2811; Packing Group: II; Shipping Name: Toxic solid, organic, n.o.s. (Vitamin D3) | ||||
Literature References: | Leibowitz, S.B., and Kantoff, P.W., Differentiating agents and the treatment of prostate cancer: Vitamin D3 and peroxisome proliferator-activated receptor γ ligands. Semin. Oncol. 30, 698-708, (2003); Welsh, J., et al., Vitamin D3 receptor as a target for breast cancer prevention. J. Nutr. 133, 2425S-2433S, (2003); Holick, M.F., Evolution and function of vitamin D. Rec. Res. Canc. Res. 164, 3-28, (2003); Palmer, H.G., et al., Genetic signatures of differentiation induced by 1α,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 63, 7799-7806, (2003); Merck 14,10019; Beil. 6,IV,4149; Aldrich MSDS 1, 1840:C / Corp MSDS 1 (2), 3609:A / FT-IR 2 (3), 4222:C / FT-IR 1 (2), 1049:D / FT-NMR 1 (3), 570:C / IR-Spectra (3), 1494:G / IR-Spectra (2), 1278:F / NMR-Reference 2 (2), 920:D / RegBook 1 (2), 2857:D / Sax 6, 787 / Sigma FT-IR 1 (1), 637:C / Structure Index 1, 457:B:7 | ||||
MSDS: | Click here. | ||||
Description: | Vitamin D acts through a receptor that is a member of the ligand-dependent transcription factor superfamily. Modulates the proliferation and differentiation of both normal and cancer cells. Has antiproliferative and antimetastatic effects on breast, colon, and prostate cancer cells. Activated vitamin D receptors in intestine and bone maintain calcium absorbance and homeostasis |